Literature DB >> 26920872

Complementary and alternative medicine use among US cancer survivors.

Gabriella M John1, Dawn L Hershman1,2,3, Laura Falci1, Zaixing Shi1, Wei-Yann Tsai3,4, Heather Greenlee5,6.   

Abstract

PURPOSE: US cancer survivors commonly use vitamins/minerals and complementary and alternative medicine (CAM). We compare use of vitamins/minerals and CAM between adult cancer survivors and cancer-free adults and estimate annual out-of-pocket expenses.
METHODS: Data on self-reported vitamin/mineral and CAM use in the past 12 months from the cross-sectional 2012 US National Health Interview Survey were used to estimate prevalence of use and out-of-pocket expenditures. The cohort included adults with (n = 2977) and without (n = 30,551) a self-reported cancer diagnosis.
RESULTS: Approximately 79 % of cancer survivors and 68 % of cancer-free adults reported using ≥1 vitamins/minerals and/or CAM modality in the past year. Compared to cancer-free adults, cancer survivors were more likely to report use of vitamin/minerals (75 vs. 61 %, P < 0.001), non-vitamin/mineral natural products (24 vs. 19 %, P < 0.001), manipulative and body-based therapies (19 vs. 17 %, P = 0.03), and alternative medical systems (5 vs. 4 %, P = 0.04). Adult cancer survivors and cancer-free adults spent an annual estimated $6.7 billion and $52 billion out-of-pocket, respectively, on vitamins/minerals and CAM. Survivors spent 60 % of the total on vitamins/minerals ($4 billion), 18 % ($1.2 billion) on non-vitamin/mineral natural products, and 7 % ($0.5 billion) on massage.
CONCLUSIONS: Compared with cancer-free adults, a higher proportion of cancer survivors report vitamin/mineral and CAM use. Cancer survivors, who accounted for 6.9 % of the total population, accrued more than 11.4 % of the annual out-of-pocket costs on vitamins/minerals and CAM spent by US adults. IMPLICATIONS FOR CANCER SURVIVORS: Given the high use of vitamins/minerals and CAM in cancer survivors, studies are needed to analyze health outcomes and the cost/benefit ratio of such use.

Entities:  

Keywords:  Cancer; Complementary medicine; Complementary therapies; Healthcare costs; Vitamins

Mesh:

Year:  2016        PMID: 26920872      PMCID: PMC5001939          DOI: 10.1007/s11764-016-0530-y

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  30 in total

Review 1.  The distribution of health care costs and their statistical analysis for economic evaluation.

Authors:  A Briggs; A Gray
Journal:  J Health Serv Res Policy       Date:  1998-10

2.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

3.  Full disclosure--out-of-pocket costs as side effects.

Authors:  Peter A Ubel; Amy P Abernethy; S Yousuf Zafar
Journal:  N Engl J Med       Date:  2013-10-17       Impact factor: 91.245

4.  Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Gary E Deng; Sarah M Rausch; Lee W Jones; Amitabh Gulati; Nagi B Kumar; Heather Greenlee; M Catherine Pietanza; Barrie R Cassileth
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

5.  Summary health statistics for the U.S. population: National Health Interview Survey, 2012.

Authors:  Patricia F Adams; Whitney K Kirzinger; Michael Martinez
Journal:  Vital Health Stat 10       Date:  2013-12

6.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

7.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

8.  Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study.

Authors:  Melissa Farmer Miller; Keith M Bellizzi; Meryl Sufian; Anita H Ambs; Michael S Goldstein; Rachel Ballard-Barbash
Journal:  J Am Diet Assoc       Date:  2008-03

9.  Defining and measuring chronic conditions: imperatives for research, policy, program, and practice.

Authors:  Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh
Journal:  Prev Chronic Dis       Date:  2013-04-25       Impact factor: 2.830

10.  Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer.

Authors:  Alissa R Link; Marilie D Gammon; Judith S Jacobson; Page Abrahamson; Patrick T Bradshaw; Mary Beth Terry; Susan Teitelbaum; Alfred Neugut; Heather Greenlee
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-12       Impact factor: 2.629

View more
  32 in total

1.  Diagnoses associated with dietary supplement use in a national dataset.

Authors:  Julie Friedman; Jen Birstler; Gayle Love; David Kiefer
Journal:  Complement Ther Med       Date:  2019-02-23       Impact factor: 2.446

Review 2.  Yoga for symptom management in oncology: A review of the evidence base and future directions for research.

Authors:  Suzanne C Danhauer; Elizabeth L Addington; Lorenzo Cohen; Stephanie J Sohl; Marieke Van Puymbroeck; Natalia K Albinati; S Nicole Culos-Reed
Journal:  Cancer       Date:  2019-04-01       Impact factor: 6.860

3.  Applying New Models of Care to Meet Patient Needs in Integrative Oncology.

Authors:  Anand Dhruva; Chloe E Atreya; Maria T Chao
Journal:  J Altern Complement Med       Date:  2018 Sep/Oct       Impact factor: 2.579

4.  Use of complementary and alternative medicine and breast cancer survival in the Health, Eating, Activity, and Lifestyle Study.

Authors:  Marian L Neuhouser; Ashley Wilder Smith; Stephanie M George; James T Gibson; Kathy B Baumgartner; Richard Baumgartner; Catherine Duggan; Leslie Bernstein; Anne McTiernan; Rachel Ballard
Journal:  Breast Cancer Res Treat       Date:  2016-10-21       Impact factor: 4.872

5.  The Use of Complementary Health Approaches Among U.S. Adults with a Recent Cancer Diagnosis.

Authors:  Tainya C Clarke
Journal:  J Altern Complement Med       Date:  2017-09-20       Impact factor: 2.579

6.  Oncology Association of Naturopathic Physicians: Principles of Care Guidelines.

Authors:  E Marsden; G Nigh; S Birdsall; H Wright; M Traub
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

7.  A randomized double-blind placebo-controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer.

Authors:  Margaret M Lubas; Belinda N Mandrell; William L Greene; Carrie R Howell; Robbin Christensen; Cara I Kimberg; Chenghong Li; Kirsten K Ness; Deo Kumar Srivastava; Melissa M Hudson; Leslie L Robison; Kevin R Krull; Tara M Brinkman
Journal:  Pediatr Blood Cancer       Date:  2021-10-21       Impact factor: 3.167

Review 8.  The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Authors:  Nicolas Iragorri; Claire de Oliveira; Natalie Fitzgerald; Beverley Essue
Journal:  Curr Oncol       Date:  2021-03-15       Impact factor: 3.677

Review 9.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

Review 10.  Pancreas Cancer-Associated Pain Management.

Authors:  Andrew L Coveler; Jonathan Mizrahi; Bory Eastman; Smith Jim Apisarnthanarax; Shalini Dalal; Terry McNearney; Shubham Pant
Journal:  Oncologist       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.